GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poseida Therapeutics Inc (STU:2RZ) » Definitions » Float Percentage Of Total Shares Outstanding

Poseida Therapeutics (STU:2RZ) Float Percentage Of Total Shares Outstanding : 72.29% (As of Sep. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Poseida Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Poseida Therapeutics's float shares is 70.21 Mil. Poseida Therapeutics's total shares outstanding is 97.13 Mil. Poseida Therapeutics's float percentage of total shares outstanding is 72.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Poseida Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Poseida Therapeutics's Institutional Ownership is 30.82%.

Poseida Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Poseida Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=70.21/97.13
=72.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poseida Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poseida Therapeutics Inc (STU:2RZ) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
MACK CBUS DNTH GRTS IVVD CRMD IMRX ATXS INZY AEON OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PSTX:USA
Address
9390 Towne Centre Drive, Suite 200, San Diego, CA, USA, 92121
Website
https://www.poseida.com
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Poseida Therapeutics Headlines

No Headlines